BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

Alpharx Pharma Pages on BioPortfolio:

BioPortfolio - AlphaRx Incorporated
5 Oct 2009 ... AlphaRx is an emerging pharmaceutical company engaged in the development of therapeutic products using proprietary drug delivery ...
http://www.bioportfolio.com/biocorporate/603-AlphaRx_Incorpo...

Biotechnology News Delirium Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, ... AlphaRx Concludes GAI-122 Formulation Development Intended For The ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Tobramycin
AlphaRx's inhaled Tobramycin nanoparticle formulation provides 300% more ... PARI Pharma Receives 2nd ODD From EMEA; Moves Inhaled Tobramycin - eFlow ...
http://www.bioportfolio.com/indepth/Tobramycin.html...

BioPortfolio - Cheil Jedang Corporation - CJ Pharma news
Pharmaceutical Technology: Oct 3 2009 1:59AM Matching: pharma. AlphaRx and Riso Pharma Sign Collaboration and Licensing Agreement ...
http://www.bioportfolio.com/biocorporate/2650-Cheil+Jedang+C...

BioPortfolio - Delirium
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug ... AlphaRx and Gaia BioPharma Report Positive Efficacy Results in a ...
http://www.bioportfolio.com/indepth/Delirium.html...

AlphaRX Announces Commercialization of LipoBloc(TM) and LipoLette(TM)
BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug ... AlphaRx's highly soluble LipoBloc* has been proven effective in the ...
http://www.bioportfolio.com/news/alpha_7.htm...

ALRX - AlphaRx Announces Commercialization of "Flexogan" Topical ...
16 Jul 2002 ... BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug ... AlphaRx is targeting the 34 million Americans who take ...
http://www.bioportfolio.com/news/alpha_8.htm...

BioPortfolio Client Press Releases Site Map
Completion of flotation on TSX & AIM YM raises c$15 million (gross) · AlphaRx Announces Letter of Intent to acquire pharmaceutical manufacturing company ...
http://www.bioportfolio.com/news/site_map.htm...

BioPortfolio Limited Stakeholder Opinions: Cystic Fibrosis - A ...
BioPortfolio's Biotechnology and Pharmaceutical products and services of ... Zysolin (nanoparticle-encapsulated formulation of tobramycin, AlphaRx) 111 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_18.html...

BioPortfolio News: BioPortfolio News 2009-09-30
08:00: AlphaRx and Riso Pharma Sign Collaboration and Licensing Agreement. http: //www.bioportfolio.com/news/AlphaRx_and_Riso_Pharma_Sign_Collaboration_and. ...
http://www.bioportfolio.com/news/2009-09-30.html...

Results from other life science and pharmaceutical sites:

::AlphaRx
AlphaRx and Riso Pharma Sign Collaboration and Licensing Agreement; September 14 , 2009 AlphaRx Presents Company Overview and New Product Candidates at the ...
http://www.alpharx.com/...

AlphaRx Inc. And Proprius Pharmaceuticals Announce License ...
MARKHAM, Ontario and SAN DIEGO, April 11 /PRNewswire-FirstCall/ -- AlphaRx Inc. and Proprius Pharmaceuticals, Inc. today announced they have entered into a ...
http://www.biospace.com/news_story.aspx?NewsEntityId=15028...

AlphaRx and Riso Pharma Sign Collaboration and Licensing Agreement
MARKHAM, Ontario, September 30, 2009 - AlphaRx Inc., has entered into an exclusive collaboration and licensing agreement with Riso Pharma Tech for the
...
http://www.alpharx.com/docs09/pdf/RisoCollaboration.pdf...

AlphaRx, Inc. Company Profile - Yahoo! Finance
Headlines for AlphaRx, Inc. •, AlphaRx and Riso Pharma Sign Collaboration and Licensing Agreement PR Newswire - Wed Sep 30 ...
http://biz.yahoo.com/ic/113/113804.html...

Microsoft PowerPoint - AlphaRx IR Website Sept 2009
AlphaRx In Brief. A small publicly traded specialty pharma focusing on difficult to treat indications. Drug delivery: reformulating well known and FDA ...
http://www.alpharx.com/docs09/pdf/AlphaRx%20IR%20Website%20S...

AlphaRX Inc. - Google Finance
AlphaRx, Inc., (AlphaRx), is a pharmaceutical company, engaged in the research and development of therapeutic products using drug delivery technologies, ...
http://www.google.com/finance?q=OTC:ALRX...

AlphaRx and Proprius Pharmaceuticals Announce License Agreement ...
11 Apr 2006 ... AlphaRx has advanced a portfolio of proprietary technologies into Phase I and Phase II human clinical trials. About Proprius Pharmaceuticals ...
http://www.alpharx.com/pdf/Indaflexfinal041006.pdf...

BioSpace - Proprius Pharmaceuticals News, Search Jobs, Events
AlphaRx Inc. (ALRX) And Proprius Pharmaceuticals Achieve Enrollment Objective In Phase II Trial Of Indaflex(TM) For Osteoarthritis Of The Knee 12/11/2006 ...
http://www.biospace.com/company_profile.aspx?CompanyId=10017...

BioWorld Snapshots - Sample
AlphaRx will locate the facility in Venturepharm's development complex but ... Agreement for the manufacture of Kevetrin active pharmaceutical ingredient ...
http://www.bioworld.com/servlet/com.accumedia.web.Dispatcher...

Osteoarthritis - Biotech, Clinical Research, Pharmaceutical News ...
AlphaRx Inc. (ALRX) And Proprius Pharmaceuticals Announce License Agreement For Indaflex(TM), A Phase II Topical NSAID For Osteoarthritis 4/11/2006 More. ...
http://www.biospace.com/news_by_disease_results.aspx?TheRxId...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.